Walgreens further reduces stake in Cencora for $1.1B

Struggling pharmacy chain Walgreens has further reduced its stake in drug distributor Cencora to 10% from 12% to raise funding. The recent sale of more Cencora shares for approximately $1.1bn will be used to pay down Walgreens’ debt and fund its operations as it turns its focus towards health services.